Call for Abstracts
Abstract submission period
The Submission Deadline is April 8 (Mon) 2024.
- The abstract submission form requires a Web browser of Microsoft Internet Explorer, Netscape, Mozilla Firefox, Safari, and Google Chrome. Please use the latest version of browsers.
- Your e-mail address is required for online abstract submission. Please make sure your e-mail address is valid so that we can contact you.
- All general presentation will be oral presentation.
- Confirmations for submission and notifications of acceptance/rejection will be e-mailed to the registered address. Please make sure that the presenting author receives the messages.
JSGCT Travel Grant 2024
JSGCT will award "JSGCT Travel Grant 2024" to young researchers (under 45 years old) who will make excellent presentations at the JSGCT Annual Meeting in hopes of further development of their research. Please see the requirements below for details.
Abstract Categories
| A. Basic science and technologies | |
|---|---|
| A1 | Gene regulation |
| A2 | Gene editing |
| A3 | Oligonucleotides |
| A4 | RNAi technologies and miRNA |
| A5 | Stem cells （include ES cells and iPS cells） |
| A6 | Tissue engineering |
| A7 | Cell processing |
| A8 | Bioimaging |
| A9 | Immune/Inflammation regulation |
| A10 | Others |
| B. Vector development and gene transfer technologies | |
| B1 | Viral vectors |
| B2 | Non-viral vectors |
| B3 | Gene editing |
| B4 | Other gene transfer technologies |
| C. Preclinical studies for gene and cell therapy （include studies for molecular pathogenesis） |
|
| C1 | Genetic diseases |
| C2 | Cancer |
| C3 | Cardiovascular diseases |
| C4 | Neurologic, ophthalmic, and musculo-skeletal diseases |
| C5 | Infectious diseases and vaccines |
| C6 | Cell therapy |
| C7 | Regenerative medicine |
| C8 | Gene editing |
| C9 | Others |
| D. Clinical studies for gene and cell therapy | |
| D1 | Genetic diseases |
| D2 | Cancer |
| D3 | Cardiovascular diseases |
| D4 | Neurologic, ophthalmic, and musculo-skeletal diseases |
| D5 | Infectious diseases and vaccines |
| D6 | Cell therapy |
| D7 | Gene editing |
| D8 | Others |
| E. Regulatory Science | |
| E1 | Regulatory science |
Guideline for abstract submission and eligibility
Abstract submission
- The contents of the abstracts should be original and unpublished/unpresented work.
Submission must be made through online. - Abstract and application form should be filled in Japanese or English.
- Abstract title: Less than 50 words. (For English)
- Abstract body: Less than 450 words. (For English)
- Do not include any figures, charts, illustrations and photographs.
- Please be sure to check errors and misspelling before submitting your abstract.
Accepted abstracts will be published in the Congress Program exactly as you submitted.
Notification
- When the abstract submission is completed, the first author will receive a confirmation of registration by e-mail from the Meeting-Secretariat. (If e-mail is not received within 1 week, please contact the Meeting-Secretariat by e-mail at jsgct2024-office@umin.ac.jp)
- The 30th JSGCT Scientific Program Committee will review all abstracts around May 2024 and first authors will be notified with the results by the end of May 2024.
- Confirmation for submission and notifications of acceptance/rejection will be e-mailed to the registered address. Please make sure your e-mail address is valid to receive the messages.
Eligibility for submission
- For first or presenting authors who are Non-Japanese citizens and residing outside of Japan are not required to be a member of JSGCT.
- For first or presenting authors who are Japanese citizens and Non-Japanese citizens residing in Japan, must be a member of JSGCT. To become a member, please visit Member admission.
Presentation formats
- All general presentation will be oral presentation.
- The abstract category which relates best should be selected from the list of topics given in the application form.
Disclosure of Conflict of Interest (COI)
For oral presentations, please include a slide disclosing the state of COI in your PowerPoint presentation by using the sample templates.
If you have any queries, please contact:
Congress Coordinator of JSGCT 2024
c/o DO Convention, Inc.
5F, 2-23 Kandaawajicho, Chiyodaku, Tokyo 101-0063
E-mail：jsgct2024-office@umin.ac.jp